The Markets and President Trump
Yesterday’s Presidential Press Conference was a bit on the unpresidential side! Will this affect the equities markets? We will know soon enough!
Click download link to listen on this device: Download Show
Al,
Trumps news conference yesterday was brilliant. He is exposing everyone, including the deep state you are now talking about…
He has done more for the American people in his first four weeks, than any other president in history has done. Main Street America and the world will thrive like no other time in history based on his actions. But, he won’t be able to stop the coming stock crash and debt bubble…
ditto
And the stock crash and debt bubble IS unwinding the deep state😉
The U.S. Can Learn From India’s Move To Digital Currency?
In short, we can learn to not let it happen here. In August, Obama’s Defense Secretary, Ashton Carter, appointed Jeff Bezos to the little-known and highly secretive Defense Innovation Advisory Board. This for me confirmed that Bezos was an integral part of the Deep State, which I began to suspect when Amazon’s cloud computing division started receiving contracts from various Deep State divisions (like the CIA). This “advisory” board is chaired by Googles Eric Schmidt.
http://investmentresearchdynamics.com/the-u-s-can-learn-from-indias-move-to-digital-currency/
Obama Coup D’état – Gen. Flynn’s Leaker Will Be Caught, 1501
Published on Feb 16, 2017
Joseph DiGenova, the former U.S. Attorney for the District of Columbia, is one of the most powerful attorneys in Washington, and probably THE most powerful attorney that our team can completely trust.
Ryan is part of the establishment.
Why expect him to help Trump?
Like the rest of them. Get with the program and do right for America, or be exposed…
Just look how stupid Graham and McCain look.
O/T BioNap Research – Week Ending Feb 17th (VTGN, RDHL, IMNP, BioCEO)
Immune Pharmaceuticals (IMNP) CEO, Daniel Teper, spoke at the 2017 Disruptive Growth & Healthcare Conference earlier this week (click here for the webcast).
Dr. Teper provided some interesting nuggets for investors in his short talk. Firstly, it sounds like we may finally get to see some data with bertilimumab in bullous pemphigoid in the coming weeks! That’s huge! Investors have been wanting to see the Phase 2 BP data for a while now. I think the data will be positive. Why? Because Dr. DT noted during the call that they are expanding the trial to move from naive to treatment-resistant patients. The Phase 2 study is an open-label design. That likely means DT has seen the data and is making a decision to move forward / expand the study. It’s subtle, but if you are going to invest in small-cap biopharma stocks you need to know how to read these little hints. Hopefully, positive Phase 2 BP data acts as a nice catalyst for the shares.
The second nugget is that it sounds like the Phase 3 trial with Ceplene is nearing initiation. That tells me the company has a path to approval in the U.S. and that funding at Cytovia must be near. More – much needed – good news for IMNP.
Bill Bennett had a succinct review of yesterday’s press conference and he’s mostly spot on.
Thanks Chris…..for speaking out on the deep state……..